Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
[Assessment of a year of teaching of medical psychology].

Concours medical

MISSENARD AR, GELLY R.
PMID: 14474580
Concours Med. 1961 Dec 09;83:6299-310.

No abstract available.

Cite
MISSENARD AR, GELLY R. [Assessment of a year of teaching of medical psychology]. Concours Med. 1961;83:6299-310
MISSENARD, A. R., & GELLY, R. (1961). [Assessment of a year of teaching of medical psychology]. Concours medical, 836299-310.
MISSENARD, A R, and GELLY, R. "[Assessment of a year of teaching of medical psychology]." Concours medical vol. 83 (1961): 6299-310.
MISSENARD AR, GELLY R. [Assessment of a year of teaching of medical psychology]. Concours Med. 1961 Dec 09;83:6299-310. French. PMID: 14474580.
Copy Download .nbib Format: NLM
Absence of cardiac damage induced by long-term intensive endurance exercise training: A cardiac magnetic resonance and exercise echocardiography analysis in masters athletes.

American journal of preventive cardiology

Missenard O, Gabaudan C, Astier H, Desmots F, Garnotel E, Massoure PL.
PMID: 34611636
Am J Prev Cardiol. 2021 May 16;7:100196. doi: 10.1016/j.ajpc.2021.100196. eCollection 2021 Sep.

OBJECTIVES: It is under debate whether the long-term practice of intensive endurance exercise induces chronic cardiac damage such as myocardial fibrosis and ventricle contractile dysfunction. Multimodality analysis was performed to evaluate myocardial damage induced by long term intensive endurance...

Cite
Missenard O, Gabaudan C, Astier H, et al. Absence of cardiac damage induced by long-term intensive endurance exercise training: A cardiac magnetic resonance and exercise echocardiography analysis in masters athletes. Am J Prev Cardiol. 2021;7:100196doi: 10.1016/j.ajpc.2021.100196.
Missenard, O., Gabaudan, C., Astier, H., Desmots, F., Garnotel, E., & Massoure, P. L. (2021). Absence of cardiac damage induced by long-term intensive endurance exercise training: A cardiac magnetic resonance and exercise echocardiography analysis in masters athletes. American journal of preventive cardiology, 7100196. https://doi.org/10.1016/j.ajpc.2021.100196
Missenard, Olivier, et al. "Absence of cardiac damage induced by long-term intensive endurance exercise training: A cardiac magnetic resonance and exercise echocardiography analysis in masters athletes." American journal of preventive cardiology vol. 7 (2021): 100196. doi: https://doi.org/10.1016/j.ajpc.2021.100196
Missenard O, Gabaudan C, Astier H, Desmots F, Garnotel E, Massoure PL. Absence of cardiac damage induced by long-term intensive endurance exercise training: A cardiac magnetic resonance and exercise echocardiography analysis in masters athletes. Am J Prev Cardiol. 2021 May 16;7:100196. doi: 10.1016/j.ajpc.2021.100196. eCollection 2021 Sep. PMID: 34611636; PMCID: PMC8387285.
Copy Download .nbib Format: NLM
Management of chordoma of the sacrum and mobile spine.

Orthopaedics & traumatology, surgery & research : OTSR

Court C, Briand S, Mir O, Péchoux CL, Lazure T, Missenard G, Bouthors C.
PMID: 34890865
Orthop Traumatol Surg Res. 2021 Dec 07;103169. doi: 10.1016/j.otsr.2021.103169. Epub 2021 Dec 07.

Chordoma is a very rare, poorly known malignancy, with slow progression, mainly located in the sacrum and spine. All age groups may be affected, with a diagnostic peak in the 5

Cite
Court C, Briand S, Mir O, et al. Management of chordoma of the sacrum and mobile spine. Orthop Traumatol Surg Res. 2021;103169doi: 10.1016/j.otsr.2021.103169.
Court, C., Briand, S., Mir, O., Péchoux, C. L., Lazure, T., Missenard, G., & Bouthors, C. (2021). Management of chordoma of the sacrum and mobile spine. Orthopaedics & traumatology, surgery & research : OTSR, 103169. https://doi.org/10.1016/j.otsr.2021.103169
Court, Charles, et al. "Management of chordoma of the sacrum and mobile spine." Orthopaedics & traumatology, surgery & research : OTSR vol. (2021): 103169. doi: https://doi.org/10.1016/j.otsr.2021.103169
Court C, Briand S, Mir O, Péchoux CL, Lazure T, Missenard G, Bouthors C. Management of chordoma of the sacrum and mobile spine. Orthop Traumatol Surg Res. 2021 Dec 07;103169. doi: 10.1016/j.otsr.2021.103169. Epub 2021 Dec 07. PMID: 34890865.
Copy Download .nbib Format: NLM
Characteristics, survivals and risk factors of surgical site infections after En Bloc sacrectomy for primary malignant sacral tumors at a single center.

Orthopaedics & traumatology, surgery & research : OTSR

Marmouset D, Haseny B, Dukan R, Saint-Etienne A, Missenard G, Court C, Bouthors C.
PMID: 35007788
Orthop Traumatol Surg Res. 2022 Jan 07;103197. doi: 10.1016/j.otsr.2022.103197. Epub 2022 Jan 07.

INTRODUCTION: For prolonged survival, primary malignant sacral tumors (PMST) are treated by En Bloc sacrectomy. Few studies analyzed specifically the surgical site infections (SSI) for this condition and whether they impact on the patients' survivals.OBJECTIVES: The objectives were to...

Cite
Marmouset D, Haseny B, Dukan R, et al. Characteristics, survivals and risk factors of surgical site infections after En Bloc sacrectomy for primary malignant sacral tumors at a single center. Orthop Traumatol Surg Res. 2022;103197doi: 10.1016/j.otsr.2022.103197.
Marmouset, D., Haseny, B., Dukan, R., Saint-Etienne, A., Missenard, G., Court, C., & Bouthors, C. (2022). Characteristics, survivals and risk factors of surgical site infections after En Bloc sacrectomy for primary malignant sacral tumors at a single center. Orthopaedics & traumatology, surgery & research : OTSR, 103197. https://doi.org/10.1016/j.otsr.2022.103197
Marmouset, Damien, et al. "Characteristics, survivals and risk factors of surgical site infections after En Bloc sacrectomy for primary malignant sacral tumors at a single center." Orthopaedics & traumatology, surgery & research : OTSR vol. (2022): 103197. doi: https://doi.org/10.1016/j.otsr.2022.103197
Marmouset D, Haseny B, Dukan R, Saint-Etienne A, Missenard G, Court C, Bouthors C. Characteristics, survivals and risk factors of surgical site infections after En Bloc sacrectomy for primary malignant sacral tumors at a single center. Orthop Traumatol Surg Res. 2022 Jan 07;103197. doi: 10.1016/j.otsr.2022.103197. Epub 2022 Jan 07. PMID: 35007788.
Copy Download .nbib Format: NLM
Wearable cardioverter defibrillator: Bridge or alternative to implantation?.

World journal of cardiology

Barraud J, Cautela J, Orabona M, Pinto J, Missenard O, Laine M, Thuny F, Paganelli F, Bonello L, Peyrol M.
PMID: 28706588
World J Cardiol. 2017 Jun 26;9(6):531-538. doi: 10.4330/wjc.v9.i6.531.

The implantable cardioverter-defibrillator (ICD) is effective to prevent sudden cardiac death (SCD) in selected patients with heart disease known to be at high risk for ventricular arrhythmia. Nevertheless, this invasive and definitive therapy is not indicated in patients with...

Cite
Barraud J, Cautela J, Orabona M, et al. Wearable cardioverter defibrillator: Bridge or alternative to implantation?. World J Cardiol. 2017;9(6):531-538doi: 10.4330/wjc.v9.i6.531.
Barraud, J., Cautela, J., Orabona, M., Pinto, J., Missenard, O., Laine, M., Thuny, F., Paganelli, F., Bonello, L., & Peyrol, M. (2017). Wearable cardioverter defibrillator: Bridge or alternative to implantation?. World journal of cardiology, 9(6), 531-538. https://doi.org/10.4330/wjc.v9.i6.531
Barraud, Jeremie, et al. "Wearable cardioverter defibrillator: Bridge or alternative to implantation?." World journal of cardiology vol. 9,6 (2017): 531-538. doi: https://doi.org/10.4330/wjc.v9.i6.531
Barraud J, Cautela J, Orabona M, Pinto J, Missenard O, Laine M, Thuny F, Paganelli F, Bonello L, Peyrol M. Wearable cardioverter defibrillator: Bridge or alternative to implantation?. World J Cardiol. 2017 Jun 26;9(6):531-538. doi: 10.4330/wjc.v9.i6.531. PMID: 28706588; PMCID: PMC5491470.
Copy Download .nbib Format: NLM
Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial.

Current oncology (Toronto, Ont.)

Assi H, Missenard G, Terrier P, Le Pechoux C, Bonvalot S, Vanel D, Meric JB, Tursz T, Lecesne A.
PMID: 21151406
Curr Oncol. 2010 Nov;17(6):23-31. doi: 10.3747/co.v17i6.578.

PURPOSE: To improve outcomes in localized osteosarcoma and to reduce the duration of preoperative chemotherapy, we conducted a phase ii trial assessing the efficacy of an intensive protracted regimen without methotrexate (api-ai regimen) in adolescent and adult patients with...

Cite
Assi H, Missenard G, Terrier P, et al. Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial. Curr Oncol. 2010;17(6):23-31doi: 10.3747/co.v17i6.578.
Assi, H., Missenard, G., Terrier, P., Le Pechoux, C., Bonvalot, S., Vanel, D., Meric, J. B., Tursz, T., & Lecesne, A. (2010). Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial. Current oncology (Toronto, Ont.), 17(6), 23-31. https://doi.org/10.3747/co.v17i6.578
Assi, H, et al. "Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial." Current oncology (Toronto, Ont.) vol. 17,6 (2010): 23-31. doi: https://doi.org/10.3747/co.v17i6.578
Assi H, Missenard G, Terrier P, Le Pechoux C, Bonvalot S, Vanel D, Meric JB, Tursz T, Lecesne A. Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial. Curr Oncol. 2010 Nov;17(6):23-31. doi: 10.3747/co.v17i6.578. PMID: 21151406; PMCID: PMC2993436.
Copy Download .nbib Format: NLM
Management of chordoma of the sacrum and mobile spine.

Orthopaedics & traumatology, surgery & research : OTSR

Court C, Briand S, Mir O, Le Péchoux C, Lazure T, Missenard G, Bouthors C.
PMID: 34890865
Orthop Traumatol Surg Res. 2021 Dec 07;103169. doi: 10.1016/j.otsr.2021.103169. Epub 2021 Dec 07.

Chordoma is a very rare, poorly known malignancy, with slow progression, mainly located in the sacrum and spine. All age groups may be affected, with a diagnostic peak in the 5th decade of life. Clinical diagnosis is often late....

Cite
Court C, Briand S, Mir O, et al. Management of chordoma of the sacrum and mobile spine. Orthop Traumatol Surg Res. 2021;103169doi: 10.1016/j.otsr.2021.103169.
Court, C., Briand, S., Mir, O., Le Péchoux, C., Lazure, T., Missenard, G., & Bouthors, C. (2021). Management of chordoma of the sacrum and mobile spine. Orthopaedics & traumatology, surgery & research : OTSR, 103169. https://doi.org/10.1016/j.otsr.2021.103169
Court, Charles, et al. "Management of chordoma of the sacrum and mobile spine." Orthopaedics & traumatology, surgery & research : OTSR vol. (2021): 103169. doi: https://doi.org/10.1016/j.otsr.2021.103169
Court C, Briand S, Mir O, Le Péchoux C, Lazure T, Missenard G, Bouthors C. Management of chordoma of the sacrum and mobile spine. Orthop Traumatol Surg Res. 2021 Dec 07;103169. doi: 10.1016/j.otsr.2021.103169. Epub 2021 Dec 07. PMID: 34890865.
Copy Download .nbib Format: NLM
A Model-Strengthened Imaging Biomarker for Survival Prediction in EGFR-Mutated Non-small-cell Lung Carcinoma Patients Treated with Tyrosine Kinase Inhibitors.

Bulletin of mathematical biology

Collin A, Groza V, Missenard L, Chomy F, Colin T, Palussière J, Saut O.
PMID: 33966172
Bull Math Biol. 2021 May 08;83(6):68. doi: 10.1007/s11538-021-00902-7.

Non-small-cell lung carcinoma is a frequent type of lung cancer with a bad prognosis. Depending on the stage and genomics, several therapeutical approaches are used. Tyrosine Kinase Inhibitors (TKI) may be successful for a time in the treatment of...

Cite
Collin A, Groza V, Missenard L, et al. A Model-Strengthened Imaging Biomarker for Survival Prediction in EGFR-Mutated Non-small-cell Lung Carcinoma Patients Treated with Tyrosine Kinase Inhibitors. Bull Math Biol. 2021;83(6):68doi: 10.1007/s11538-021-00902-7.
Collin, A., Groza, V., Missenard, L., Chomy, F., Colin, T., Palussière, J., & Saut, O. (2021). A Model-Strengthened Imaging Biomarker for Survival Prediction in EGFR-Mutated Non-small-cell Lung Carcinoma Patients Treated with Tyrosine Kinase Inhibitors. Bulletin of mathematical biology, 83(6), 68. https://doi.org/10.1007/s11538-021-00902-7
Collin, Annabelle, et al. "A Model-Strengthened Imaging Biomarker for Survival Prediction in EGFR-Mutated Non-small-cell Lung Carcinoma Patients Treated with Tyrosine Kinase Inhibitors." Bulletin of mathematical biology vol. 83,6 (2021): 68. doi: https://doi.org/10.1007/s11538-021-00902-7
Collin A, Groza V, Missenard L, Chomy F, Colin T, Palussière J, Saut O. A Model-Strengthened Imaging Biomarker for Survival Prediction in EGFR-Mutated Non-small-cell Lung Carcinoma Patients Treated with Tyrosine Kinase Inhibitors. Bull Math Biol. 2021 May 08;83(6):68. doi: 10.1007/s11538-021-00902-7. PMID: 33966172.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries